This is a preprint article, it offers immediate access but has not been peer reviewed.

Psoralen Mitigates Triptolide-Induced Ovarian Injury by Suppressing Ovarian Granulosa Cell Apoptosis Through the Activation of Nrf2 Signaling Pathway

57 Pages Posted: 15 Aug 2024

See all articles by Yang Tang

Yang Tang

Hunan University of Chinese Medicine

Xuebin Yang

Hunan University of Chinese Medicine

Lulu Zhong

Hunan University of Chinese Medicine

Yang Tan

Hunan University of Chinese Medicine

Wenhui Bi

Hunan University of Chinese Medicine

Jin Liu

Hunan University of Chinese Medicine

Jiandong Lu

Shenzhen Traditional Chinese Medicine Hospital

Feng Zhou

Hunan University of Chinese Medicine

Gang Pei

Hunan University of Chinese Medicine

Abstract

As a diterpenoid epoxide natural product purified from medicinal plant Tripterygium wilfordii Hook F, triptolide (TP) is extensively investigated for its significant anti-inflammatory and immunosuppressive activity. However, the application of this treatment is limited by its significant ovarian toxicity. Psoralen (Pso), a principal bioactive compound isolated from the fruits of Psoralea corylifolia L., has attracted increasing attention due to its antioxidant, anti-inflammatory, and anti-tumorigenic activities. A TP-induced ovarian injury rat model was established by administered TP intraperitoneally for 14 days. At the same time, the rats were subjected to Pso gavage intervention. At the end of treatment, histological pathology, apoptosis, mitochondrial dysfunction, and nuclear factor-erythroid 2-related factor (Nrf2) signal of ovarian tissues were detected. Moreover, the protective effects of Pso on TP-drived mitochondrial dysfunction and apoptosis in granulosa cells (GCs) were revealed in vitro. Our results indicated that Pso effectively reduced the levels of the histological damage in rats with TP intervention. The findings from both in vivo and in vitro studies indicate that Pso may mitigate apoptosis, mitochondrial dysfunction, and the inhibition of the Nrf2 signaling pathway induced by TP. Moreover, the effects of Nrf2 signaling inhibitor ML385 on Pso were found to significantly attenuate the above outcomes. Collectively, Pso alleviated TP-induced ovarian damage by inhibiting GC apoptosis driven by mitochondrial dysfunction, and the mechanism was in part associated with the activating Nrf2 signaling pathway. Our research results illuminate the advantageous impact of Pso on TP-induced ovarian injury, providing new insights for the therapeutic comprehension of TP-induced ovarian toxicity.

Note:
Funding declaration: This work was supported by the research project of Hunan University of Chinese Medicine (2024XJZB005).

Conflict of Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Ethical Approval: All animal procedures were performed in line with the principles of the Animal Experimental Center of Hunan University of Chinese Medicine (reference number: LL2022110913).

Keywords: Psoralen Triptolide Granulosa cell Mitochondrial dysfunction Apoptosis Nrf2

undefined

Suggested Citation

Tang, Yang and Yang, Xuebin and Zhong, Lulu and Tan, Yang and Bi, Wenhui and Liu, Jin and Lu, Jiandong and Zhou, Feng and Pei, Gang, Psoralen Mitigates Triptolide-Induced Ovarian Injury by Suppressing Ovarian Granulosa Cell Apoptosis Through the Activation of Nrf2 Signaling Pathway. Available at SSRN: https://ssrn.com/abstract=4915114

Yang Tang

Hunan University of Chinese Medicine ( email )

China

Xuebin Yang

Hunan University of Chinese Medicine ( email )

China

Lulu Zhong

Hunan University of Chinese Medicine ( email )

China

Yang Tan

Hunan University of Chinese Medicine ( email )

China

Wenhui Bi

Hunan University of Chinese Medicine ( email )

China

Jin Liu

Hunan University of Chinese Medicine ( email )

China

Jiandong Lu

Shenzhen Traditional Chinese Medicine Hospital ( email )

Shenzhen, 518033
China

Feng Zhou

Hunan University of Chinese Medicine ( email )

China

Gang Pei (Contact Author)

Hunan University of Chinese Medicine ( email )

China

0 Citations

    Do you have a job opening that you would like to promote on SSRN?

    Paper statistics

    Downloads
    17
    Abstract Views
    96
    PlumX Metrics